Loading
EXT2 (Exostosin-2) is an enzyme. In the public catalogues the evidence so far is association rather than a proven role. Tied to Ovarian cancer, Skin cancer and Breast cancer.
Glycosyltransferase forming with EXT1 the heterodimeric heparan sulfate polymerase which catalyses the elongation of the heparan sulfate glycan backbone. Glycan backbone extension consists in the alternating transfer of (1->4)-beta-D-GlcA and (1->4)-alpha-D-GlcNAc residues from their respective UDP-sugar donors. Both EXT1 and EXT2 are required for the full activity of the polymerase since EXT1 bears the N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity within the complex while EXT2 carries the glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity.
Open Targets scores its association with cancer at 0.72 (direct and indirect evidence; datatypes literature 0.84, affected pathway 0.25, genetic association 0.64, somatic mutation 0.98).
In plain words · EXT2 (Exostosin-2) is an enzyme. In the public catalogues the evidence so far is association rather than a proven role. Tied to Ovarian cancer, Skin cancer and Breast cancer.
EXT2 (Exostosin-2) is an enzyme. In the public catalogues the evidence so far is association rather than a proven role. Tied to Ovarian cancer, Skin cancer and Breast cancer.
Glycosyltransferase forming with EXT1 the heterodimeric heparan sulfate polymerase which catalyses the elongation of the heparan sulfate glycan backbone.
No product in this corpus aims at EXT2 yet. Inhibitors are shaped to fit the enzyme's active site so the reaction the cancer relies on stops.
First described 1996. Earliest sequence paper UniProt cites for the protein: Stickens D.J. et al, Nat. Genet, 1996, "The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes". Source.
Sources: HGNC HGNC:3513 (approved symbol, name, aliases, locus and cross-references (hgnc_complete_set.txt)); UniProt Q93063 (protein name, function text, keywords and locations (REST API)); Open Targets ENSG00000151348 (association with cancer (MONDO_0004992) 0.72; per-cancer scores at or above 0.5: ovarian cancer 0.57, skin cancer 0.51, breast cancer 0.50 (GraphQL API, CC0))
Glycosyltransferase forming with EXT1 the heterodimeric heparan sulfate polymerase which catalyses the elongation of the heparan sulfate glycan backbone. Glycan backbone extension consists in the alternating transfer of (1->4)-beta-D-GlcA and (1->4)-alpha-D-GlcNAc residues from their respective UDP-sugar donors. Both EXT1 and EXT2 are required for the full activity of the polymerase since EXT1 bears the N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity within the complex while EXT2 carries the glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity. Heparan sulfate proteoglycans are ubiquitous components of the extracellular matrix and play an important role in tissue homeostasis and signalling. Location: Golgi apparatus membrane; Golgi apparatus, cis-Golgi network membrane; Endoplasmic reticulum membrane; Secreted (UniProt). Locus 11p11.2 (HGNC).
Query for this target: (TITLE:"EXT2" OR ABSTRACT:"EXT2" OR TITLE:"exostosin glycosyltransferase 2" OR ABSTRACT:"exostosin glycosyltransferase 2" OR TITLE:"Exostosin-2" OR ABSTRACT:"Exostosin-2") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about EXT2, not a curated reading list.